DATA GRAPHICS | Finance
CRISPR stocks track ETFs lower: Data Byte
March 6, 2021 1:23 AM UTC
Fund flows for a pair of ETFs from ARK Investment with billions in assets may be one explanation for the recent weakness in a basket of gene editing stocks.
Gene editing companies CRISPR Therapeutics AG (NASDAQ:CRSP), Editas Medicine Inc. (NASDAQ:EDIT), Intellia Therapeutics Inc. (NASDAQ:NTLA) and Beam Therapeutics Inc. (NASDAQ:BEAM) have all had a difficult past two weeks with share prices down 22-31%. ...